It is up to us to dissect out each candidate's position on all the issues we deem important, to assess their integrity, management skills, and leadership qualities that allows us to choose a leader.
Ronald Ernest Paul is a native of Pennsylvania who received his medical training at Duke. He completed a residency in ob/gyn at the University of Pittsburgh, after serving as an Air Force Flight Surgeon during the early years of the Vietnam War. He moved to Texas in 1968, where he began his medical practice as the only ob/gyn in Brazoria County. Dr. Paul has delivered more than 4,000 babies, and, perhaps presaging his current antifederalist, libertarian economic leanings, refused to accept Medicare or Medicaid payments for his services, providing care under a customized payment plan instead. After a decade of delivering babies, he leveraged his busy obstetric practice to win election to Congress in 1978. It seems that Dr. Paul had delivered the babies of most of the voting mothers in his congressional district. He has been in Congress ever since.
Looking at the world through a libertarian's eyes
Paul goes by the moniker "Dr. No," since he consistently votes against popular entitlement programs not explicitly authorized by the constitution.3 To his credit, he "walks the talk." In addition to his self-imposed prohibition on accepting taxpayer-funded public health insurance payments for his medical care, he refused to allow his children to accept federal student loans. He also refuses a congressional pension, contending that it is an abuse of power. Not surprisingly, Paul believes that most of our health-care system's problems can be linked directly to inappropriate government meddling. Here are some of Paul's positions on health-care topics:
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More